256 related articles for article (PubMed ID: 30171227)
21. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
22. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
Balekian AA; Wisnivesky JP; Gould MK
Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
[TBL] [Abstract][Full Text] [Related]
23. Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
Abdollah F; Sun M; Schmitges J; Thuret R; Tian Z; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):95-103. PubMed ID: 22330991
[TBL] [Abstract][Full Text] [Related]
24. Race, prostate cancer survival, and membership in a large health maintenance organization.
Robbins AS; Whittemore AS; Van Den Eeden SK
J Natl Cancer Inst; 1998 Jul; 90(13):986-90. PubMed ID: 9665146
[TBL] [Abstract][Full Text] [Related]
25. Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer.
Dell'Oglio P; Boehm K; Trudeau V; Tian Z; Larcher A; Leyh-Bannurah SR; Moschini M; Capitanio U; Shariat SF; Briganti A; Montorsi F; Saad F; Karakiewicz PI
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1037-1045. PubMed ID: 27478167
[TBL] [Abstract][Full Text] [Related]
26. Racial and Ethnic Trends in Prostate Cancer Incidence and Mortality in Philadelphia, PA: an Observational Study.
Zeigler-Johnson C; Keith S; McIntire R; Robinson T; Leader A; Glanz K
J Racial Ethn Health Disparities; 2019 Apr; 6(2):371-379. PubMed ID: 30520002
[TBL] [Abstract][Full Text] [Related]
27. Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.
White A; Coker AL; Du XL; Eggleston KS; Williams M
Cancer; 2011 Mar; 117(5):1080-8. PubMed ID: 21351084
[TBL] [Abstract][Full Text] [Related]
28. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?
Curtis E; Quale C; Haggstrom D; Smith-Bindman R
Cancer; 2008 Jan; 112(1):171-80. PubMed ID: 18040998
[TBL] [Abstract][Full Text] [Related]
29. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
[TBL] [Abstract][Full Text] [Related]
30. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
[TBL] [Abstract][Full Text] [Related]
31. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
Liss DT; Baker DW
Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
[TBL] [Abstract][Full Text] [Related]
32. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
33. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
[TBL] [Abstract][Full Text] [Related]
34. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.
Davis BA; Aminawung JA; Abu-Khalaf MM; Evans SB; Su K; Mehta R; Wang SY; Gross CP
J Natl Compr Canc Netw; 2017 Mar; 15(3):346-354. PubMed ID: 28275035
[No Abstract] [Full Text] [Related]
35. Race and overall survival in men diagnosed with prostate cancer in the Department of Defense Military Health System, 1990-2010.
Alexander M; Zhu K; Cullen J; Byrne C; Brown D; Shao S; Rusiecki J
Cancer Causes Control; 2019 Jun; 30(6):627-635. PubMed ID: 30997591
[TBL] [Abstract][Full Text] [Related]
36. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
Weiner AB; Keeter MK; Manjunath A; Meeks JJ
Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
[TBL] [Abstract][Full Text] [Related]
37. Racial disparities in survival after diagnosis of prostate cancer in Kentucky, 2001-2010.
Antwi S; Tucker TC; Coker AL; Fleming ST
Am J Mens Health; 2013 Jul; 7(4):306-16. PubMed ID: 23339130
[TBL] [Abstract][Full Text] [Related]
38. Association of race and health care system with disease stage and survival in veterans with larynx cancer.
Voora RS; Kotha NV; Kumar A; Qiao EM; Qian AS; Panuganti BA; Banegas MP; Weissbrod PA; Stewart TF; Rose BS; Orosco RK
Cancer; 2021 Aug; 127(15):2705-2713. PubMed ID: 33799314
[TBL] [Abstract][Full Text] [Related]
39. Comparison of demographics, disease characteristics, and outcomes between Black and White patients with myelodysplastic syndromes: A population-based study.
Lesegretain A; Brunner A; King AJ; Laadem A; Fell G; Fathi AT
Leuk Res; 2023 Feb; 125():107006. PubMed ID: 36580877
[TBL] [Abstract][Full Text] [Related]
40. Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.
Mahal BA; Gerke T; Awasthi S; Soule HR; Simons JW; Miyahira A; Halabi S; George D; Platz EA; Mucci L; Yamoah K
Eur Urol Oncol; 2022 Feb; 5(1):18-29. PubMed ID: 34446369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
